VCRE
Vicore Pharma Holding AB
8.80$
+1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 99.9% | 99.9% | 99.9% | 99.7% | 99.6% | |
| 96.7% | 66.0% | 36.0% | 47.4% | 35.0% | 46.1% | |
| – | 0.1% | – | – | 0.0% | – | |
| 5.5% | 5.8% | 7.0% | 10.1% | 8.0% | 8.2% | |
| 5.5% | 5.7% | 6.8% | 9.7% | 7.9% | 7.9% | |
| 2.5% | 3.4% | 3.0% | 3.2% | 3.2% | 2.2% | |
| 94.5% | 94.2% | 93.0% | 89.9% | 92.0% | 91.8% | |
| -120.6% | – | – | -157.6% | – | – | |
| 19.6% | 21.7% | 24.0% | 23.1% | 26.1% | 30.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.